Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001415889-24-022989
Filing Date
2024-09-05
Accepted
2024-09-05 19:53:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3254
  Complete submission text file 0001415889-24-022989.txt   4757
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address
Litton Mark James (Reporting) CIK: 0001604834 (see all company filings)

Type: 144

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39503 | Film No.: 241282673
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)